Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives

References

• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42. doi:10.1053/j.gastro.2011.10.001
   PubMed Web of Science ®Google Scholar
• Glade MJ, Meguid MM. A glance at. dietary emulsifiers, the human intestinal mucus and microbiome, and dietary fiber. Nutrition. 2016;32(5):609–614. doi:10.1016/j.nut.2015.12.036
   PubMed Web of Science ®Google Scholar
• Yang Y, Chung owyang GW, Wu GD. Summary of the Asia America Assembly of IBD (AAA IBD 2016): east meets west–the rising incidence of IBD in Asia as a paradigm for environmental effects on the pathogenesis of immune-mediated disease. Gastroenterology. 2016;151(6):e1–e5. doi:10.1016/j.physbeh.2017.03.040
   PubMed Web of Science ®Google Scholar
• Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018;67(9):1726–1738. doi:10.1136/gutjnl-2017-315866
   PubMed Web of Science ®Google Scholar
• Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563–573. doi:10.1038/ajg.2011.44
   PubMed Web of Science ®Google Scholar
• Wood JA, Halmos EP, Taylor KM, Gibson PR. The role of epidemiological evidence from prospective population studies in shaping dietary approaches to therapy in Crohn’s disease. Mol Nutr Food Res. 2021;65(5):2000294. doi:10.1002/mnfr.202000294
   Web of Science ®Google Scholar
• Monteiro CA, Moubarac JC, Cannon G, Ng SW, Popkin B. Ultra-processed products are becoming dominant in the global food system. Obes Rev. 2013;14(S2):21–28. doi:10.1111/obr.12107
   PubMedGoogle Scholar
• Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374. doi:10.1136/bmj.n1554
   PubMedGoogle Scholar
• Lo C-H, Khandpur N, Rossato SL, et al. Ultra-processed foods and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol. 2021. doi:10.1016/j.cgh.2021.08.031
   Web of Science ®Google Scholar
• Halmos EP, Mack A, Gibson PR. Review article: emulsifiers in the food supply and implications for gastrointestinal disease. Aliment Pharmacol Ther. 2019;49(1):41–50. doi:10.1111/apt.15045
   PubMed Web of Science ®Google Scholar
• Dimitrijevic D, Shaw AJ, Florence A. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. J Pharm Pharmacol. 2000;52(2):157–162. doi:10.1211/0022357001773805
   PubMed Web of Science ®Google Scholar
• Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92–96. doi:10.1038/nature14232
   PubMed Web of Science ®Google Scholar
• Watt J, Marcus R. Carrageenan-induced ulceration of the large intestine in the Guinea pig. Gut. 1971;12(2):164–171. doi:10.1136/gut.12.2.164
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Dudeja PK, Tobacman JK. Tumor necrosis factor α-induced inflammation is increased but apoptosis is inhibited by common food additive carrageenan. J Biol Chem. 2010;285(50):39511–39522. doi:10.1074/jbc.M110.159681
   PubMed Web of Science ®Google Scholar
• Chassaing B, Compher C, Bonhomme B, et al. Randomized controlled-feeding study of dietary emulsifier carboxymethyl cellulose reveals detrimental impacts on the gut microbiota and metabolome. Gastroenterology. 2021. doi:10.1053/j.gastro.2021.11.006
   Google Scholar
• Roberts CL, Keita ÅV, Duncan SH, et al. Translocation of Crohn’s disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut. 2010;59(10):1331–1339. doi:10.1136/gut.2009.195370
   PubMed Web of Science ®Google Scholar
• Wedlake L, Slack N, Andreyev HJN, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis. 2014;20(3):576–586. doi:10.1097/01.MIB.0000437984.92565.31
   PubMed Web of Science ®Google Scholar
• Ordovas JM, Ferguson LR, Tai ES, Mathers JC. Personalised nutrition and health. BMJ. 2018;361(k2173):1–7. doi:10.1136/bmj.k2173
   Google Scholar
• Celis-Morales C, Livingstone KM, Marsaux CFM, et al. Effect of personalized nutrition on health-related behaviour change: evidence from the Food4Me European randomized controlled trial. Int J Epidemiol. 2017;46(2):578–588. doi:10.1093/ije/dyw186
   PubMed Web of Science ®Google Scholar
• Ferguson LR, De Caterina R, Görman U, et al. Guide and position of the international society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition. J Nutrigenet Nutrigenomics. 2016;9(1):12–27. doi:10.1159/000445350
   PubMedGoogle Scholar
• Wyatt P, Berry SE, Finlayson G, et al. Postprandial glycaemic dips predict appetite and energy intake in healthy individuals. Nat Metab. 2021;3(4):523–529. doi:10.1038/s42255-021-00383-x
   PubMedGoogle Scholar
• Moore SE, McMullan M, McEvoy CT, McKinley MC, Woodside JV. The effectiveness of peer-supported interventions for encouraging dietary behaviour change in adults: a systematic review. Public Health Nutr. 2019;22. doi:10.1017/S1368980018003294
   Web of Science ®Google Scholar
• Cederholm T, Jensen GL, Correia MI, et al. GLIM criteria for the diagnosis of malnutrition – a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9. doi:10.1016/j.clnu.2018.08.002
   PubMed Web of Science ®Google Scholar
• Filippi J, Al-Jaouni R, Wiroth JB, Hébuterne X, Schneider SM. Nutritional deficiencies in patients with Crohn’s disease in remission. Inflamm Bowel Dis. 2006;12(3):185–191. doi:10.1097/01.MIB.0000206541.15963.c3
   PubMed Web of Science ®Google Scholar
• Kondrup J, Rasmussen H, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22:321–336. doi:10.1016/S0261-5614(02)00214-5
   PubMed Web of Science ®Google Scholar
• BAPEN. The “MUST” explanatory booklet: a guide to the “Malnutrition Universal Screening Tool” (‘MUST’) for adults; 2011. Available from: https://www.health.gov.il/download/ng/N500-19.pdf. Accessed January 9, 2023.
   Google Scholar
• Day AS, Yao CK, Costello SP, Andrews JM, Bryant RV. Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: a systematic scoping review. Appetite. 2021;167:105650. doi:10.1016/j.appet.2021.105650
   PubMed Web of Science ®Google Scholar
• Czuber-Dochan W, Morgan M, Hughes LD, Lomer MCE, Lindsay JO, Whelan K. Perceptions and psychosocial impact of food, nutrition, eating and drinking in people with inflammatory bowel disease: a qualitative investigation of food-related quality of life. J Hum Nutr Diet. 2020;33(1):115–127. doi:10.1111/jhn.12668
   PubMed Web of Science ®Google Scholar
• Dunleavy K, Ungaro R, Manning L, Novak J, Gold S, Colombel J. Vitamin C deficiency in inflammatory bowel disease: the forgotten micronutrient. J Crohns Colitis. 2020;14(Supplement_1):S209–S209. doi:10.1093/ecco-jcc/jjz203.272
   Google Scholar
• Bischoff SC, Escher J, Hébuterne X, et al. ESPEN practical guideline: clinical Nutrition in inflammatory bowel disease. Clin Nutr. 2020;39(3):632–653. doi:10.1016/j.clnu.2019.11.002
   PubMed Web of Science ®Google Scholar
• Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohns Colitis. 2020;14(1):4–22. doi:10.1093/ecco-jcc/jjz180
   PubMed Web of Science ®Google Scholar
• Raine T, Spinelli A, Bonovas S, et al. ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment. J Crohns Colitis. 2022;16(2):179–189. doi:10.1093/ecco-jcc/jjab177
   PubMed Web of Science ®Google Scholar
• Chiu E, Oleynick C, Raman M, Bielawska B. Optimizing inpatient nutrition care of adult patients with inflammatory bowel disease in the 21st century. Nutrients. 2021;13(5):1581. doi:10.3390/nu13051581
   PubMed Web of Science ®Google Scholar
• Danese S, Solitano V, Jairath V, Biroulet LP. The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment). Gut. 2022;71:2380–2387. doi:10.1136/gutjnl-2022-327025
   PubMed Web of Science ®Google Scholar
• Wellens J, Vermeire S, Sabino J. Let food be thy medicine — its role in Crohn’s disease. Nutrients. 2021;13(832):1–16. doi:10.3390/nu13030832
   Google Scholar
• Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohn’s disease in children. Aliment Pharmacol Ther. 2007;26(6):795–806. doi:10.1111/j.1365-2036.2007.03431.x
   PubMed Web of Science ®Google Scholar
• Gunasekeera V, Mendall MA, Chan D, Kumar D. Treatment of Crohn’s disease with an IgG4-guided exclusion diet: a randomized controlled trial. Dig Dis Sci. 2016;61(4):1148–1157. doi:10.1007/s10620-015-3987-z
   PubMed Web of Science ®Google Scholar
• Komperød MJ, Sommer C, Mellin-Olsen T, Iversen PO, Røseth AG, Valeur J. Persistent symptoms in patients with Crohn’s disease in remission: an exploratory study on the role of diet. Scand J Gastroenterol. 2018;53(5):573–578. doi:10.1080/00365521.2017.1397736
   PubMed Web of Science ®Google Scholar
• Levine A, Wine E, Assa A, et al. Crohn’s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology. 2019;157(2):440–450.e8. doi:10.1053/j.gastro.2019.04.021
   PubMed Web of Science ®Google Scholar
• Svolos V, Hansen R, Nichols B, et al. Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology. 2019;156(5):1354–1367.e6. doi:10.1053/j.gastro.2018.12.002
   PubMed Web of Science ®Google Scholar
• Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: discovery service for Endeavour College of Natural Health Library. Nutr J. 2014;13(5):1–7. doi:10.1186/1475-2891-13-5
   PubMedGoogle Scholar
• Konijeti GG, Kim N, Lewis JD, et al. Efficacy of the autoimmune protocol diet for inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(11):2054–2060. doi:10.1097/MIB.0000000000001221
   PubMed Web of Science ®Google Scholar
• Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet. 2018;31(2):239–255. doi:10.1111/jhn.12530
   PubMed Web of Science ®Google Scholar
• Sabino J, Lewis JD, Colombel JF. Treating inflammatory bowel disease with diet: a taste test. Gastroenterology. 2019;157(2):295–297. doi:10.1053/j.gastro.2019.06.027
   PubMed Web of Science ®Google Scholar
• Noor NM, Verstockt B, Parkes M, Lee JC. Personalised medicine in Crohn’s disease. lancet Gastroenterol Hepatol. 2020;5(1):80–92. doi:10.1016/S2468-1253(19)30340-1
   PubMed Web of Science ®Google Scholar
• Schwärzler J, Mayr L, Vich Vila A, et al. PUFA-induced metabolic enteritis as a fuel for Crohn’s disease. Gastroenterology. 2022;162(6):1690–1704. doi:10.1053/j.gastro.2022.01.004
   PubMed Web of Science ®Google Scholar
• Sabino J. Understanding the role of PUFAs in Crohn’s disease. Gastroenterology. 2022;162(6):1590–1591. doi:10.1053/j.gastro.2022.02.048
   PubMed Web of Science ®Google Scholar
• Triggs CM, Munday K, Hu R, et al. Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn’s disease population. Mutat Res. 2010;690(1–2):123–138. doi:10.1016/j.mrfmmm.2010.01.020
   PubMed Web of Science ®Google Scholar
• Cohen AB, Lee D, Long MD, et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013;58(5):1322–1328. doi:10.1007/s10620-012-2373-3.Dietary
   PubMed Web of Science ®Google Scholar
• Pittet V, Vaucher C, Maillard MH, et al. Information needs and concerns of patients with inflammatory bowel disease: what can we learn from participants in a bilingual clinical cohort? PLoS One. 2016;11(3):1–17. doi:10.1371/journal.pone.0150620
   Web of Science ®Google Scholar
• Armstrong H, Mander I, Zhang Z, Armstrong D, Wine E. Not all fibers are born equal; variable response to dietary fiber subtypes in IBD. Front Pediatr. 2021;8:1–15. doi:10.3389/fped.2020.620189
   Web of Science ®Google Scholar
• Beukema M, Faas MM, de Vos P. The effects of different dietary fiber pectin structures on the gastrointestinal immune barrier: impact via gut microbiota and direct effects on immune cells. Exp Mol Med. 2020;52(9):1364–1376. doi:10.1038/s12276-020-0449-2
   PubMed Web of Science ®Google Scholar
• Cox SR, Lindsay JO, Fromentin S, et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology. 2020;158(1):176–188.e7. doi:10.1053/j.gastro.2019.09.024
   PubMed Web of Science ®Google Scholar
• Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Muir JG, Gibson PR. Consistent prebiotic effect on gut microbiota with altered fodmap intake in patients with crohn s disease: a randomised, controlled cross-over trial of well-defined diets. Clin Transl Gastroenterol. 2016;7(4):e164–10. doi:10.1038/ctg.2016.22
   PubMedGoogle Scholar
• Loughman A, Staudacher HM. Treating the individual with diet: is gut microbiome testing the answer? Lancet Gastroenterol Hepatol. 2020;5(5):437. doi:10.1016/S2468-1253(20)30023-6
   PubMed Web of Science ®Google Scholar
• Gardner CD, Trepanowski JF, Gobbo LCD, et al. Effect of low-fat VS low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion the DIETFITS randomized clinical trial. JAMA. 2018;319(7):667–679. doi:10.1001/jama.2018.0245
   PubMed Web of Science ®Google Scholar
• Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079–1094. doi:10.1016/j.cell.2015.11.001
   PubMed Web of Science ®Google Scholar
• Mirkov MU, Verstockt B, Cleynen I. Genetics of inflammatory bowel disease: beyond NOD2. Lancet Gastroenterol Hepatol. 2017;2(3):224–234. doi:10.1016/S2468-1253(16)30111-X
   PubMed Web of Science ®Google Scholar
• Petermann I, Triggs CM, Huebner C, et al. Mushroom intolerance: a novel diet gene interaction in Crohn’s disease. Br J Nutr. 2009;102(4):506–508. doi:10.1017/S0007114509276446
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Masuda H, Ishii Y, Nishida Y, Kobayashi M, Asai S. Decreased expression of thioredoxin interacting protein mRNA in inflamed colonic mucosa in patients with ulcerative colitis. Oncol Rep. 2007;18(3):531–535. doi:10.3892/or.18.3.531
   PubMed Web of Science ®Google Scholar
• Laing BB, Lim AG, Ferguson LR. A personalised dietary approach-A way forward to manage nutrient deficiency, effects of the western diet, and food intolerances in inflammatory bowel disease. Nutrients. 2019;11(7):1–28. doi:10.3390/nu11071532
   Web of Science ®Google Scholar
• Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1847–1850. doi:10.1158/1055-9965.EPI-05-0456
   PubMed Web of Science ®Google Scholar
• Sudhakar P, Alsoud D, Wellens J, Verstockt S. Tailoring multi-omics to inflammatory bowel diseases: all for one and one for all. JCC. 2022;16:1306–1320. doi:10.1016/S2468-1253(21)00065-0
   Google Scholar
• Zeng Z, Mukherjee A, Zhang H. From genetics to epigenetics, roles of epigenetics in inflammatory bowel disease. Front Genet. 2019;10:1–17. doi:10.3389/fgene.2019.01017
   PubMed Web of Science ®Google Scholar
• Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011;3(4):503–518. doi:10.2217/epi.11.71
   PubMed Web of Science ®Google Scholar
• Biesiekierski JR, Jalanka J, Staudacher HM. Can gut microbiota composition predict response to dietary treatments? Nutrients. 2019;11(5):1–15. doi:10.3390/nu11051134
   Web of Science ®Google Scholar
• Bennet SMP, Böhn L, Störsrud S, et al. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut. 2018;67(5):872–881. doi:10.1136/gutjnl-2016-313128
   PubMed Web of Science ®Google Scholar
• Qi Q, Li J, Yu B, et al. Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies. Gut. 2021;71:1095–1105. doi:10.1136/gutjnl-2021-324053
   PubMed Web of Science ®Google Scholar
• Tebani A, Bekri S. Paving the way to precision nutrition through metabolomics. Front Nutr. 2019;6:1–10. doi:10.3389/fnut.2019.00041
   PubMed Web of Science ®Google Scholar
• Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–585. doi:10.1038/nm.3145
   PubMed Web of Science ®Google Scholar
• Tang WHW, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–1584. doi:10.1056/nejmoa1109400
   PubMed Web of Science ®Google Scholar
• Aldubayan MA, Pigsborg K, Gormsen SMO, et al. A double-blinded, randomized, parallel intervention to evaluate biomarker-based nutrition plans for weight loss: the PREVENTOMICS study. Clin Nutr. 2022;41:101890. doi:10.1016/j.clnu.2022.06.032
   Web of Science ®Google Scholar
• Kim AH, Roberts C, Feagan BG, et al. Developing a standard set of patient-centred outcomes for inflammatory bowel disease-an international, cross-disciplinary consensus. J Crohns Colitis. 2018;12(4):408–418. doi:10.1093/ecco-jcc/jjx161
   PubMed Web of Science ®Google Scholar
• Laville M, Segrestin B, Alligier M, et al. Evidence-based practice within nutrition: what are the barriers for improving the evidence and how can they be dealt with? Trials. 2017;18(1). doi:10.1186/s13063-017-2160-8
   Google Scholar
• Staudacher HM, Irving PM, Lomer MCE, Whelan K. The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. Proc Nutr Soc. 2017;76(3):203–212. doi:10.1017/S0029665117000350
   PubMed Web of Science ®Google Scholar
• Dron L, Taljaard M, Cheung YB, et al. The role and challenges of cluster randomised trials for global health. Lancet Glob Health. 2021;9(5):e701–e710. doi:10.1016/S2214-109X(20)30541-6
   PubMed Web of Science ®Google Scholar
• Kaplan HC, Opipari-Arrigan L, Yang J, et al. Personalized research on diet in ulcerative colitis and crohn’s disease: a series of N-of-1 diet trials. Am J Gastroenterol. 2022;117(6):902–917. doi:10.14309/ajg.0000000000001800
   PubMed Web of Science ®Google Scholar
• Dimbleby H. The national food strategy: the plan. Environ Rural Aff. 2021;290. doi:10.2307/j.ctt4cgqfz.3
   Google Scholar